Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

5.930 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cybin Inc. Common Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD
Via Investor Brand Network
Topics Death
News headline image
Cybin Announces Final Adelia Milestone Achievement
From Cybin Inc.
Via Business Wire
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Dosing Participants in CYB003 Trial for Treatment of MDD
Via Investor Brand Network
News headline image
Cybin Inc. Announces First Participants Dosed in its Phase 1/2a Trial of CYB003 for the Treatment of Major Depressive Disorder
From Cybin Inc.
Via Business Wire
How Psychedelics Startups Are Improving Their Resilience
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Transformation of Psychedelic Sector
Via Investor Brand Network
Israeli Study identifies Bacterial Footprint in PTSD Sufferers
Via Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming H.C. Wainwright Global Investment Conference
Via Investor Brand Network
News headline image
Cybin to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
From Cybin Inc.
Via Business Wire
How Meditation, Psychedelics Can Boost Healing
Via Investor Brand Network
FT-104: Field Trip’s Latest Psychedelic Drug Candidate
Via Investor Brand Network
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
Via Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Partner Receive Required Schedule I License from DEA for First-in-Human Clinical Trial
Via Investor Brand Network
News headline image
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
From Cybin Inc.
Via Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Results of Annual Meeting of Shareholders
Via Investor Brand Network
News headline image
Cybin Announces Results of Shareholders’ Meeting
From Cybin Inc.
Via Business Wire
Psilocybin Lawsuit Filed in Canada May Boost Global Psychedelics Reform Efforts
Via Investor Brand Network
Topics Lawsuit
Brain Fingerprinting Adolescents Could Predict Future Mental-Health Issues
Via Investor Brand Network
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unveils Equity Program, Releases Q1 Financial Report
Via Investor Brand Network
Topics Intellectual Property
News headline image
CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program
From Cybin Inc.
Via Business Wire
News headline image
Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights
From Cybin Inc.
Via Business Wire
Toronto Firm Receives First Federal Government Funding to Study Psilocybin
Via Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
Via Investor Brand Network
New Poll Finds Most Americans Support Research on Psychedelics for Military Members
Via Investor Brand Network
Topics Cannabis
Study Finds That Difficulty Sleeping, Financial Stressors Increase Mental Health Risk in University Students
Via Investor Brand Network
Research Finds Psychedelics May Open Door to Self-Actualization
Via Investor Brand Network
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Cleared for Historic Study, Begins Enrolling Participants
Via Investor Brand Network
News headline image
Cybin to Present at the Canaccord Genuity 42nd Annual Growth Conference
From Cybin Inc.
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.